Advertisement
MedTech Business – August 12, 2026
The U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center has awarded a five-year national Non-Expendable Equipment (NX EQ) contract for quantitative neuromuscular monitoring to TrillaMed, LLC, the authorized U.S. federal distributor of the Senzime TetraGraph system.
Science News – August 12, 2026
Researchers at the University of Gothenburg and their international colleagues have identified a seven-protein panel that could improve blood-based testing for Alzheimer’s disease.
MedTech Business – August 11, 2026
XVIVO’s heart preservation technology, XVIVO Heart Assist Transport system, has received CE certificates, making it available to any heart transplant center throughout Europe.
Collaboration – August 11, 2026
Novo Nordisk and Amazon Web Services (AWS) have announced a strategic partnership to accelerate drug discovery and modernise Novo Nordisk’s operations through agentic AI and cloud technologies.
MedTech Business – August 11, 2026
Medicover and the minority shareholders has entered an agreement to divest 100 per cent of equity in Medicover Hospitals India to funds managed by global investment firm KKR.
Collaboration – August 11, 2026
The Swedish Hospital at Home platform provider Cuviva has announced an expanded global cooperation with Royal Philips to advance transitional care solutions.
Clinical Trials – August 4, 2026
Nykode Therapeutics has presented comprehensive preclinical and clinical data on VB10.NEO, its individualized neoantigen therapy (INT), at the Neoantigen Summit in Amsterdam, reinforcing the program as a differentiated platform ready for strategic partnership.
Clinical Trials – July 14, 2026
Evaxion has presented new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1.
Biotech article – July 13, 2026
BioArctic’s partner Eisai has presented new data at the 2026 Alzheimer’s Association International Conference (AAIC), held in London, July 12-15, demonstrating that the Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) formulation offers efficacy and safety comparable to intravenous (IV) administration in people with early Alzheimer’s disease.
Clinical Trials – June 30, 2026
FluoGuide has announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial evaluating FG001 for surgical guidance in patients with oral head and neck cancer.
Clinical Trials – June 23, 2026
Elicera Therapeutics held a scientific advice meeting with the Swedish Medical Products Agency (MPA) regarding the planned first-in-human clinical study of ELC-401, the company’s iTANK-armed CAR T-cell candidate targeting IL13Ra2 in grade IV glioma.
Clinical Trials – June 18, 2026
Cantargia has reported that the first patient has been dosed in a Phase 2 clinical trial investigating nadunolimab in up to 59 current or previous smokers with multifocal high-risk lung nodules, and therefore at risk of developing lung cancer.
Almirall Nordic
This is an opportunity to combine strong execution, stakeholder engagement, and health-economic messaging in a highly impactful field role.
PharmaRelations
We are looking for a passionate commercially minded Senior Recruitment Manager who wants to make a real impact by attracting exceptional talent, strengthening client partnerships and helping us on our mission to grow individuals and companies in Life Science.
PharmaRelations
Lead strategy, consulting and business growth across the Nordic Life Science market.
PharmaRelations
We are looking for a supply chain professional with SAP experience who can support a SAP S/4HANA transition project while helping ensure continuity across selected logistics processes.
PharmaRelations
You will have the opportunity to work in a team of PV specialists, helping our clients with the best solutions depending on their needs. You will work with several clients in parallel giving you great variation in your daily work. You may also have the opportunity to mentor and support other PV consultants within PharmaRelations.
Thea Nordic
PharmaRelations is now looking for a Head of Clinical Operations who wants to continue to build up and develop our business in Denmark and South of Sweden (Öresundsregionen).
In a new job – August 7, 2026
Diamyd Medical has announced that Mathias Skalmstad will take up the position of Chief Financial Officer at Diamyd Medical.
In a new job – August 6, 2026
“Sandra has been an invaluable member of the Oxcia team, combining scientific excellence with a deep understanding of inflammation as well as our development programs,” says Ulrika Bergman Warpman, CEO. “We are delighted to see her take on this leadership role as we finalize the pre-clinical program for OXC-201 and progress our earlier projects including […]
In a new job – August 5, 2026
“SciBase is now entering a new phase where the strategy and foundation is in place, and I feel this is the right time to hand over responsibility to a new CEO,” says Pia Renaudin.
Careers article – June 14, 2026
Johnny Mogensen most recently comes from a position as Denmark’s research and innovation attaché in Boston, USA. He has held several positions in the Danish Agency for Higher Education and Science and has also previously been posted to Brussels as an adviser to Denmark’s EU delegation and as a national expert to the European Commission.
Career choice – June 14, 2026
Lionel Leck’s research focuses on pediatric cancer, particularly neuroblastoma – one of the most commonly diagnosed childhood cancers with a poor prognosis.
Careers article – May 5, 2026
BioNTech plans to align and consolidate its manufacturing network further where excess capacity is expected, due to evolving supply needs, mergers and acquisitions, BioNTech’s partners’ manufacturing capacities and completion of contracts, it states. The company plans to exit operations at the manufacturing sites in Idar-Oberstein, Marburg, and Singapore as well as CureVac’s sites, affecting up […]
Europe – July 13, 2026
Spanish biochemist and molecular biologist Salvador Aznar Benitah’s research focuses on how adult stem cells function in normal conditions, aging, and cancer, with particular interest in epigenetics, circadian rhythms, and the mechanisms that allow certain cancer cells to initiate metastasis.
Profiles in Science – April 22, 2026
It’s one thing to “do” physics – but it’s another to explain its fundamentals to others, and the role that physics and other sciences play in their lives.
Profiles in Science – March 23, 2026
Dr. Joanna Rorbach, principal researcher at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet, has been awarded the prestigious Göran Gustafsson Prize by the Royal Swedish Academy of Sciences (Kungliga Vetenskapsakademien).
Pharma Business – August 11, 2026
The European Commission has adopted the recent Committee for Medicinal Products for Human Use (CHMP) positive opinion recommending the approval of a type II variation for IMVANEX (MVA-BN) smallpox and mpox vaccine, extending the current marketing authorization to include children 2 to less than 12 years of age.
Agreement – August 10, 2026
Swedish Orphan Biovitrum and Innate Pharma have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma (CTCL).
Drug Development Pharma – August 4, 2026
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company’s lead oral orexin 2 receptor agonist and one of several investigational compounds in Lundbeck’s development portfolio for sleep-wake disorders.
Europe – July 8, 2026
The new hub marks an investment in software development and clinical expertise and brings together these capabilities to accelerate the path to one intelligent digital ecosystem across the full perioperative workflow.
Legal Advice article – July 7, 2026
VibroSense Dynamics has initiated legal proceedings to address a breach of the exclusive agreement signed with VibroSense’s Chinese distributor Genertec Universal Medical Group Co, a subsidiary of General Technology Holding Co.
Acquisition – July 7, 2026
Asker Healthcare Group has acquired 100% of the shares in Murray Surgical Limited, a distributor of specialist surgical and medical products to the healthcare sector in Ireland.
Biotech Business – August 10, 2026
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BI-1808, a first-in-class anti-TNFR2 antibody, for the treatment of ovarian cancer in combination with pembrolizumab.
Biotech Business – July 31, 2026
Johnson & Johnson has entered a strategic collaboration with Sail Biomedicines to advance in vivo CAR-T therapies for immune-mediated diseases.
Biotech Business – July 27, 2026
The Board of Directors of Alligator Bioscience has resolved to discontinue further independent development of mitazalimab and to strategically refocus the company’s resources on the out-licensed HLX22 project.
Science News – July 31, 2026
Researchers at the University of Turku have developed a new preclinical model that could help accelerate drug development for BAP1-deficient melanomas, a rare and highly aggressive form of melanoma that is resistant to current immunotherapies.
Science News – July 13, 2026
A landmark study led from Lund University has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the first clinical trial, and no serious side effects directly linked to the transplanted cells were seen during the first year of follow up.
Science News – July 8, 2026
High levels of influenza-specific IgA antibodies in the nasal mucosa are linked to a reduced risk of infection, according to a new study from Danderyd Hospital and SciLifeLab.
This site uses cookies
